FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086019875> ?p ?o ?g. }

• W2086019875 endingPage "411" @default.
• W2086019875 startingPage "401" @default.
• W2086019875 abstract "Alpha-tocopherol ether-linked acetic acid analog [2,5,7,8-tetramethyl-2R-(4R, 8R-12-trimethyltridecyl) chroman-6-yloxyacetic acid (α -TEA)] is a novel form of vitamin E effective at killing cancer cells but not normal cells. α -TEA alone and together with methylseleninic acid (MSA) and trans-resveratrol (t-RES) were investigated for ability to induce apoptosis, DNA synthesis arrest, and cellular differentiation and inhibit colony formation in human MDA-MB-435-F-L breast cancer cells in culture. The 3 agents alone were effective in inhibiting cell growth by each of the 4 different assays, and 3-way combination treatments synergistically inhibited cell proliferation in each assay in comparison to individual treatments. Furthermore, combinations of α -TEA, t-RES, and MSA significantly enhanced levels of apoptosis in human breast (MDA-MB-231, MCF7, and T47D) and prostate (LnCaP, PC-3, and DU-145) cancer cell lines as well as in immortalized but nontumorigenic MCF10A cells but not primary cultures of human mammary epithelial cells. Western immunoblotting confirmed the induction of apoptosis in that the 3 agents induced poly(adenosine diphosphate-ribose) polymerase cleavage, with earlier detection and more complete cleavage seen in the combination treatment. Mechanistic studies showed combination treatments to inhibit cell proliferation via downregulation of cyclin D1 and induce apoptosis via activation of caspases 8 and 9 and downregulation of prosurvival proteins FLIP and survivin. In summary, the combination of α -TEA, MSA, and t-RES is more effective than single treatments for inhibiting cell proliferation, inducing cellular differentiation, and inducing cell death by apoptosis in human cancer cells in culture." @default.
• W2086019875 created "2016-06-24" @default.
• W2086019875 creator A5000233609 @default.
• W2086019875 creator A5048696544 @default.
• W2086019875 creator A5062322263 @default.
• W2086019875 creator A5073694517 @default.
• W2086019875 creator A5073975019 @default.
• W2086019875 date "2008-04-28" @default.
• W2086019875 modified "2023-09-23" @default.
• W2086019875 title "Vitamin E Analog α -TEA, Methylseleninic Acid, andTrans-Resveratrol in Combination Synergistically Inhibit Human Breast Cancer Cell Growth" @default.
• W2086019875 cites W183117910 @default.
• W2086019875 cites W1866952059 @default.
• W2086019875 cites W1908415347 @default.
• W2086019875 cites W1919984048 @default.
• W2086019875 cites W1965734230 @default.
• W2086019875 cites W1976238224 @default.
• W2086019875 cites W1976381141 @default.
• W2086019875 cites W2004057805 @default.
• W2086019875 cites W2020305530 @default.
• W2086019875 cites W2027943537 @default.
• W2086019875 cites W2033897643 @default.
• W2086019875 cites W2045520547 @default.
• W2086019875 cites W2050110236 @default.
• W2086019875 cites W2058211036 @default.
• W2086019875 cites W2066882494 @default.
• W2086019875 cites W2074950373 @default.
• W2086019875 cites W2077219185 @default.
• W2086019875 cites W2077625194 @default.
• W2086019875 cites W2077945404 @default.
• W2086019875 cites W2079949072 @default.
• W2086019875 cites W2091117378 @default.
• W2086019875 cites W2092653407 @default.
• W2086019875 cites W2109719470 @default.
• W2086019875 cites W2111868506 @default.
• W2086019875 cites W2125253537 @default.
• W2086019875 cites W2151089147 @default.
• W2086019875 cites W2164298199 @default.
• W2086019875 cites W2200253125 @default.
• W2086019875 cites W2326148442 @default.
• W2086019875 doi "https://doi.org/10.1080/01635580701759716" @default.
• W2086019875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18444175" @default.
• W2086019875 hasPublicationYear "2008" @default.
• W2086019875 type Work @default.
• W2086019875 sameAs 2086019875 @default.
• W2086019875 citedByCount "11" @default.
• W2086019875 countsByYear W20860198752013 @default.
• W2086019875 countsByYear W20860198752015 @default.
• W2086019875 countsByYear W20860198752017 @default.
• W2086019875 countsByYear W20860198752019 @default.
• W2086019875 crossrefType "journal-article" @default.
• W2086019875 hasAuthorship W2086019875A5000233609 @default.
• W2086019875 hasAuthorship W2086019875A5048696544 @default.
• W2086019875 hasAuthorship W2086019875A5062322263 @default.
• W2086019875 hasAuthorship W2086019875A5073694517 @default.
• W2086019875 hasAuthorship W2086019875A5073975019 @default.
• W2086019875 hasConcept C121608353 @default.
• W2086019875 hasConcept C153911025 @default.
• W2086019875 hasConcept C190283241 @default.
• W2086019875 hasConcept C199835354 @default.
• W2086019875 hasConcept C2775975398 @default.
• W2086019875 hasConcept C2779723316 @default.
• W2086019875 hasConcept C29537977 @default.
• W2086019875 hasConcept C31573885 @default.
• W2086019875 hasConcept C502942594 @default.
• W2086019875 hasConcept C54355233 @default.
• W2086019875 hasConcept C55493867 @default.
• W2086019875 hasConcept C62112901 @default.
• W2086019875 hasConcept C81885089 @default.
• W2086019875 hasConcept C86803240 @default.
• W2086019875 hasConcept C96232424 @default.
• W2086019875 hasConceptScore W2086019875C121608353 @default.
• W2086019875 hasConceptScore W2086019875C153911025 @default.
• W2086019875 hasConceptScore W2086019875C190283241 @default.
• W2086019875 hasConceptScore W2086019875C199835354 @default.
• W2086019875 hasConceptScore W2086019875C2775975398 @default.
• W2086019875 hasConceptScore W2086019875C2779723316 @default.
• W2086019875 hasConceptScore W2086019875C29537977 @default.
• W2086019875 hasConceptScore W2086019875C31573885 @default.
• W2086019875 hasConceptScore W2086019875C502942594 @default.
• W2086019875 hasConceptScore W2086019875C54355233 @default.
• W2086019875 hasConceptScore W2086019875C55493867 @default.
• W2086019875 hasConceptScore W2086019875C62112901 @default.
• W2086019875 hasConceptScore W2086019875C81885089 @default.
• W2086019875 hasConceptScore W2086019875C86803240 @default.
• W2086019875 hasConceptScore W2086019875C96232424 @default.
• W2086019875 hasIssue "3" @default.
• W2086019875 hasLocation W20860198751 @default.
• W2086019875 hasLocation W20860198752 @default.
• W2086019875 hasOpenAccess W2086019875 @default.
• W2086019875 hasPrimaryLocation W20860198751 @default.
• W2086019875 hasRelatedWork W2018686893 @default.
• W2086019875 hasRelatedWork W2026380718 @default.
• W2086019875 hasRelatedWork W2039701074 @default.
• W2086019875 hasRelatedWork W2185175380 @default.
• W2086019875 hasRelatedWork W2358161411 @default.
• W2086019875 hasRelatedWork W2362964312 @default.
• W2086019875 hasRelatedWork W2374067319 @default.
• W2086019875 hasRelatedWork W2383691845 @default.

• next